Young women, mothers holding babies and some men lined up in a dusty field on the outskirts of Zimbabwe’s capital, Harare. They came for injections of a new HIV prevention drug launched in the country on Thursday, one that only needs to be administered twice a year.
Zimbabwe, where HIV has led to tens of thousands of deaths over the past two decades, is one of the first countries to roll out lenacapavir, a long-acting drug that authorities hope will slow new infections.
